You are here

Home

Clinical Trials: Heart Attack

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, January 9, 2019 - 12:00
Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue
Condition:   Myocardial Infarction
Interventions:   Combination Product: PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.;   Procedure: Surgery by sternotomy
Sponsors:   Fundació Institut Germans Trias i Pujol;   Germans Trias i Pujol Hospital
Not yet recruiting
Posted: Monday, December 3, 2018 - 12:00
Short Interval Resveratrol Trial in Cardiovascular Surgery
Conditions:   Diabetes Mellitus, Type 2;   Coronary Artery Disease
Interventions:   Dietary Supplement: Trans-resveratrol;   Dietary Supplement: Placebo
Sponsors:   Maine Medical Center;   American Heart Association
Recruiting
Posted: Tuesday, May 15, 2018 - 12:00
Longeveron Mesenchymal Stem Cells (LMSCs) Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)
Condition:   HLHS
Intervention:   Biological: Longeveron Mesenchymal Stem Cells
Sponsor:   Longeveron LLC
Recruiting
Posted: Thursday, May 3, 2018 - 12:00
A Trial of Cardiac Injections of iMP Cells During CABG Surgery
Condition:   Myocardial Fibrosis
Interventions:   Biological: iMP cells;   Other: Control injection
Sponsors:   Cell Therapy Ltd.;   Royal Brompton & Harefield NHS Foundation Trust
Not yet recruiting
Posted: Monday, March 12, 2018 - 12:00
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells With Acute Myocardial Infarction
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Not yet recruiting
Posted: Wednesday, March 7, 2018 - 12:00
CardiAMP CMI Randomized Controlled Pivotal Trial in Patients With Chronic Myocardial Ischemia and Refractory Angina
Conditions:   Refractory Angina;   Chronic Myocardial Ischemia
Interventions:   Device: CardiAMP Cell Therapy System;   Other: Sham Treatment
Sponsor:   BioCardia, Inc.
Not yet recruiting
Posted: Tuesday, February 13, 2018 - 12:00
Safety of Autologous Cord Blood Cells in HLHS Patients During Norwood Heart Surgery
Conditions:   Hypoplastic Left Heart Syndrome;   Heart Defects, Congenital;   Pediatric Disorder
Intervention:   Biological: Autologous Human Placental Cord Blood Mononuclear Cells
Sponsor:   Murdoch Childrens Research Institute
Recruiting
Posted: Thursday, February 1, 2018 - 12:00
Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)
Condition:   Heart Failure
Interventions:   Drug: CardioCell;   Drug: Placebos
Sponsors:   John Paul II Hospital, Krakow;   KCRI;   National Center for Research and Development, Poland
Not yet recruiting
Posted: Friday, January 19, 2018 - 12:00
Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)
Condition:   Myocardial Infarction
Interventions:   Drug: Cardiac Drug;   Drug: Placebos
Sponsors:   John Paul II Hospital, Krakow;   KCRI;   National Center for Research and Development, Poland
Recruiting
Posted: Thursday, January 11, 2018 - 12:00
A Trial of D-SPECT Selection and Expanded-Cell Therapy for Cardiac Shock Wave-Pretreated Ischemic Cardiomyopathy(ExCELL-ICM)
Condition:   Ischemic Cardiomyopathy
Interventions:   Combination Product: CSWT+BMMSCs;   Device: CSWT+Sham operation
Sponsor:   Shanghai 10th People's Hospital
Not yet recruiting

Pages